| MicroRNAs activate gene transcription epigenetically as an enhancer trigger M Xiao, J Li, W Li, Y Wang, F Wu, Y Xi, L Zhang, C Ding, H Luo, Y Li, ... RNA biology 14 (10), 1326-1334, 2017 | 340 | 2017 |
| Histone-Related Genes Are Hypermethylated in Lung Cancer and Hypermethylated HIST1H4F Could Serve as a Pan-Cancer Biomarker S Dong, W Li, L Wang, J Hu, Y Song, B Zhang, X Ren, S Ji, J Li, P Xu, ... Cancer Research 79 (24), 6101-6112, 2019 | 51 | 2019 |
| Reactivation of tumour suppressor in breast cancer by enhancer switching through NamiRNA network Y Liang, Q Lu, W Li, D Zhang, F Zhang, Q Zou, L Chen, Y Tong, M Liu, ... Nucleic acids research 49 (15), 8556-8572, 2021 | 36 | 2021 |
| Guide positioning sequencing identifies aberrant DNA methylation patterns that alter cell identity and tumor-immune surveillance networks J Li, Y Li, W Li, H Luo, Y Xi, S Dong, M Gao, P Xu, B Zhang, Y Liang, ... Genome research 29 (2), 270-280, 2019 | 28 | 2019 |
| MBD3L2 promotes Tet2 enzymatic activity for mediating 5-methylcytosine oxidation L Peng, Y Li, Y Xi, W Li, J Li, R Lv, L Zhang, Q Zou, S Dong, H Luo, F Wu, ... Journal of cell science 129 (5), 1059-1071, 2016 | 25 | 2016 |
| Hypermethylated PCDHGB7 as a universal cancer only marker and its application in early cervical cancer screening S Dong, Q Lu, P Xu, L Chen, X Duan, Z Mao, B Zhang, L Sui, Y Wang, ... Clinical and Translational Medicine 11 (6), 2021 | 14 | 2021 |
| Cell identity bookmarking through heterogeneous chromatin landscape maintenance during the cell cycle H Luo, Y Xi, W Li, J Li, Y Li, S Dong, L Peng, Y Liu, W Yu Human molecular genetics 26 (21), 4231-4243, 2017 | 13 | 2017 |
| Hypermethylated PCDHGB7 as a biomarker for early detection of endometrial cancer in endometrial brush samples and cervical scrapings J Yuan, Z Mao, Q Lu, P Xu, C Wang, X Xu, Z Zhou, T Zhang, W Yu, ... Frontiers in Molecular Biosciences 8, 774215, 2022 | 9 | 2022 |
| Mutually exclusive epigenetic modification on SIX6 with hypermethylation for precancerous stage and metastasis emergence tracing S Dong, Z Yang, P Xu, W Zheng, B Zhang, F Fu, Z Mao, J Yuan, H Chen, ... Signal Transduction and Targeted Therapy 7 (1), 208, 2022 | 5 | 2022 |
| UHRF1 regulates alternative splicing by interacting with splicing factors and U snRNAs in a H3R2me involved manner P Xu, L Zhang, Y Xiao, W Li, Z Hu, R Zhang, J Li, F Wu, Y Xi, Q Zou, ... Human Molecular Genetics 30 (22), 2110-2122, 2021 | 5 | 2021 |
| Preparation of 5′-O-(1-thiotriphosphate)-modified oligonucleotides using polymerase-endonuclease amplification reaction (PEAR) B Li, S Dong, J Wu, J Zhang, G Chen, Q Dong, X Zhu, X Wang Plos one 8 (7), e67558, 2013 | 5 | 2013 |
| PCDHGB7 hypermethylation-based Cervical cancer Methylation (CerMe) detection for the triage of high-risk human papillomavirus-positive women: a prospective … D Cao, Z Yang, S Dong, Y Li, Z Mao, Q Lu, P Xu, M Shao, L Pan, X Han, ... BMC medicine 22 (1), 55, 2024 | 4 | 2024 |
| Diagnosis of malignant body fluids via cancer-universal methylation in cell-free DNA Z Mao, S Dong, Y Yan, C Wang, W Li, L Wang, C Qian, Y Song, L Tong, ... JCI insight 9 (7), 2024 | 1 | 2024 |
| Rapid Genome-wide Profiling of DNA Methylation and Genetic Variation Using Guide Positioning Sequencing (GPS) B Zhang, W Li, J Li, Y Li, H Luo, Y Xi, S Dong, F Wu, WQ Yu Frontiers in Cell and Developmental Biology 12, 1457387, 2024 | | 2024 |
| Hypermethylated TAGMe as a universal-cancer-only methylation marker and its application in diagnosis and recurrence monitoring of urothelial carcinoma Z Yang, Q Chen, S Dong, P Xu, W Zheng, Z Mao, C Qian, X Zheng, L Dai, ... Journal of Translational Medicine 22 (1), 608, 2024 | | 2024 |
| Tumor marker stamp-ep9 based on methylation modification and application thereof Z Li, S Dong US Patent US20220333204A1, 2022 | | 2022 |
| Methylation-based modified tumor marker stamp-ep8 and application thereof Z Li, S Dong US Patent US20220298577A1, 2022 | | 2022 |
| Tumor marker stamp-ep7 based on methylated modification and use thereof Z Li, S Dong US Patent US20220275452A1, 2022 | | 2022 |
| Tumor marker stamp-ep3 based on methylation modification Z Li, S Dong US Patent US20220220560A1, 2022 | | 2022 |
| Tumor marker and application thereof S Dong, Z Li WO Patent WO2022142677A1, 2022 | | 2022 |
Feizhen Wu Ph.D.Institutes of Biomedical Sciences, Fudan University在 fudan.edu.cn 的电子邮件经过验证
